Memorial Sloan-Kettering is developing an extensive assortment of technologies with applications for oncology and many other areas of healthcare and science. We offer opportunities for developing new devices, diagnostics, research tools, therapeutics, and vaccines.
Explore our list of technologies available for licensing below, and filter by technology categories.
Some of our newest technologies may not appear in this list. To learn about recent developments, contact any member of our staff about your particular interests.
| Title | Categories |
|---|---|
|
2-[18F]-Labeled Compounds and PET Imaging of Tumors for Enhanced Diagnostic and Therapeutic Monitoring Purposes [SK1365] |
|
|
A Novel and Efficient Method for Fat-Free Nuclear Magnetic Imaging [SK1302] |
|
|
Acid Sphingomyelinase: A New Drug Target to Regulate Apoptosis [SK 737] |
|
|
An Effective Cancer Vaccine Combination [SK1230] |
|
|
An Improved Apparatus for One-Lung Isolation [SK1063] |
|
|
Analogs of Actinonin as Antitumor Compounds [SK 934] |
|
|
Apparatus that Facilitates Cell Growth and Screening under Variable Hydrostatic Pressures [SK1017] |
|
|
Apparatus that Improves Optics in Multi-Photon Laser Scanning Microscopes [SK 951] |
|
|
Caki-1: Human Renal Cancer Cell Line [SK1980-534 ] |
|
|
Caki-2: Human Renal Cancer Cell Line [SK2010-068] |
|
|
Calu-1: Human Lung Cancer Cell Line [SK 784] |
|
|
Calu-3: Human Lung Cancer Cell Line [SK1980-533] |
|
|
CAMA-1: Human Breast Cancer Cell Line [SK 926] |
|
|
Cancer Diagnosis and Prognosis by Determining Levels of MDM2 and p53 and Antibodies Against MDM2 [SK 596] |
|
|
Cancer Marker Discovery and Validation [SK1181] |
|
|
Caov-3 : Human Ovarian Cancer Cell Line [SK2010-069] |
|
|
Caov-4 : Human Ovarian Cancer Cell Line [SK2010-070] |
|
|
Capan-1: Human Pancreatic Adenocarcinoma Cell Line [SK 923] |
|
|
Capan-2: Human Pancreatic Adenocarcinoma Cell Line [SK2000-049] |
|
|
Cathepsin Inhibitor Combined Therapy Provides Enhanced Treatment of Solid Tumors [SK1326] |
|
